BILL PAPPAS - 27 Feb 2024 Form 4 Insider Report for METLIFE INC (MET)

Role
EVP, Global Tech. & Ops.
Signature
/s/ Anna Nazarenko, Authorized Signer
Issuer symbol
MET
Transactions as of
27 Feb 2024
Net transactions value
-$2,071,964
Form type
4
Filing time
29 Feb 2024, 16:20:13 UTC
Previous filing
05 Sep 2023
Next filing
05 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award +9,327 +20% 56,236 27 Feb 2024 Direct F1, F2
transaction MET Common Stock Award +62,924 +112% 119,160 27 Feb 2024 Direct F3
transaction MET Common Stock Tax liability $2,071,964 -29,959 -25% $69.16 89,201 27 Feb 2024 Direct F4
holding MET Common Stock 7,900 27 Feb 2024 By 2022 GRAT F2
holding MET Common Stock 17,300 27 Feb 2024 By 2023 GRAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MET Employee Stock Options (right to buy) Award $0 +27,983 $0.000000 27,983 27 Feb 2024 Common Stock 27,983 $69.16 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
F2 On November 15, 2023, 7,400 shares were distributed to the reporting person in accordance with the terms of the 2022 GRAT, and are now reported as directly owned.
F3 Shares acquired from the determination of the performance factor for and payout of 2021-2023 performance shares under the MetLife, Inc. 2015 Stock and Incentive Compensation.
F4 Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout.
F5 The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.